Aqr Capital Management LLC Curis Inc Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $205,126 - $702,051	288,910 Added 2094.16%	302,706 $298,000
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $19,350 - $42,974	-8,377 Reduced 37.78%	13,796 $33,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $118,530 - $215,485	-26,636 Reduced 54.57%	22,173 $106,000
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $112,587 - $143,573	-16,223 Reduced 24.95%	48,809 $382,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $342,148 - $747,216	45,926 Added 240.37%	65,032 $525,000
Q2 2018 Aug 14, 2018	BUY	$1.73 - $3.35 $33,053 - $64,005	19,106 New	19,106 $33,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.